MONDAY, April 7, 2025 (HealthDay News) — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications. Catherine Howden, a spokeswoman for the Centers for Medicare and Medicaid ServicesContinue Reading

WEDNESDAY, April 2, 2025 (HealthDay News) — The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform. The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide. ZepboundContinue Reading

MONDAY, March 24, 2025 (HealthDay News) — People dealing with heart disease, diabetes or obesity are behind the eight ball when it comes to their chances of living longer. But they can improve their odds if they start following a healthy plant-based diet, according to a study scheduled for presentationContinue Reading